Login

HTC CEO Yves Maitre discusses the impact of trade tensions, the competitive landscape of the 5G race, and strategic company responses. 00:10:00

Share On Facebook Share On Twitter

Cher Wang serves as the CEO / President of HTC Corp.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
The largest gold nugget in Canada: Beauce Gold Fields at PDAC 2024: Seeking the Source | PATRICK LEVASSEUR, President and CEO, Beauce Gold Fields (IE)
00:10:00
PRIMARY FOCUS IS ON DISCOVERY POTENTIAL WITH MULTIPLE OPPORTUNITIES IN STABLE OPERATING JURISDICTIONS THAT INCLUDES OVER 240,000 Ha OF PROSPECTIVE GROUND IN SASKATCHEWAN|Warren Stanyer,CEO,ALX Resources Corp
00:10:00
Unlocking Value in Junior Mining: Insights from John Black of Regulus Resources Inc. | John Black - CEO & Director, Regulus Resources Inc.
00:10:00
4GLOBAL's CEO Eloy Mazon on Leading Big Data Insights and Sports Analytics | Eloy Mazon, CEO, 4GLOBAL PLC.
00:10:00
Understanding the Importance of Life Insurance: Insights from Phil Francois, CFP® | PHILIP FRANCOIS - CERTIFIED FINANCIAL PLANNER, Owner & Financial Planner of Foundation Wealth Planning
00:10:00
Wojciech Kowalczyk, CEO of Boryszew SA, discusses the Group's first-quarter 2023 results and the revival in the automotive segment.|Wojciech Kowalczyk, CEO of Boryszew SA,
00:10:00
The team is experiencing an insane demand for BIT tokens|Alex Egorov,Head of Investments,A.partners
00:00:00
BioPorto discusses 'fantastic first half of the year' driven by antibodies and RUO NGAL Test sales - Peter Mørch Eriksen, CEO/Board Member,Bioporto
00:10:00
Challenges facing social entrepreneurs|Janade Du Plessis,General Partner,Launch Africa
00:10:00
Phoenix Global Mining: Advancing the Empire Mine in Idaho
00:00:00
Bioasis Technologies forms 'exciting' licensing agreement with Chiesi Global Rare Diseases - Deborah Rathjen, B.Sc. (Hons), Ph.D., MAICD, FTSE -Executive Chair, biOasis Technologies Inc
00:10:00
The EDV is proving safe and effective across a number of late-stage, intractable cancers like pancreatic cancer and mesothelioma| Dr Jennifer MacDiarmid , CEO OF ENGENEIC

© 2026 Nehu